Probio Cayman

Probio Cayman, a subsidiary of Genscript Biotech showcased in Hong Kong, evolved from the parent company's biologics-enhanced small business unit established in January 2019. It aims to provide pharmaceutical companies with expert services and solutions ranging from drug discovery to commercialization. The subsidiary focuses on therapeutic antibody drug development as well as gene and cell therapy.